slc25a25b Antibody

What is SLC25A25 and what cellular functions does it regulate?

SLC25A25 (solute carrier family 25 member 25) is a mitochondrial carrier protein that functions primarily as a Ca²⁺-regulated shuttle of ATP-Mg²⁺ and Pi across the inner mitochondrial membrane . This protein plays a critical role in controlling ATP homeostasis within cells . The gene encoding SLC25A25 is located on chromosome 9 in humans, with a calculated molecular weight of approximately 53 kDa (469 amino acids), although observed molecular weights of 50 kDa and 100 kDa have been reported in Western blot analyses .

Functionally, SLC25A25 contributes to:

• Regulation of mitochondrial ATP content and basal respiration

• Calcium flux across the endoplasmic reticulum

• Metabolic efficiency, particularly in skeletal muscle

• Energy homeostasis with implications for obesity resistance

Research using SLC25A25 knockout mouse models has demonstrated that this protein affects metabolic efficiency without primarily functioning in thermogenesis, suggesting its importance is likely linked to ATP production required for skeletal muscle function .

What types of SLC25A25 antibodies are currently available for research applications?

Researchers have access to several types of antibodies targeting different epitopes of SLC25A25:

Each antibody type offers specific advantages depending on experimental requirements. Polyclonal antibodies generally provide broader epitope recognition but may have higher batch-to-batch variability. Monoclonal antibodies like 4D8 offer consistent specificity but may recognize only specific isoforms or conformations of the target protein .

What species reactivity do SLC25A25 antibodies demonstrate?

The species reactivity of SLC25A25 antibodies varies depending on the specific antibody:

What are the recommended applications for SLC25A25 antibodies?

SLC25A25 antibodies have been validated for several experimental applications:

It is essential to titrate antibodies in each testing system to obtain optimal results, as the appropriate dilution may be sample-dependent . When interpreting results, researchers should be aware that SLC25A25 typically appears at its predicted molecular weight of ~53 kDa, but may also show bands at approximately 100 kDa potentially due to dimerization or post-translational modifications .

What are the recommended protocols for Western blot detection of SLC25A25?

When performing Western blot analysis for SLC25A25, researchers should follow these methodological guidelines:

Sample Preparation:

• Prepare whole cell lysates or mitochondrial fractions (preferred for enhanced sensitivity)

• Use an appropriate lysis buffer containing protease inhibitors

• For mitochondrial enrichment, perform differential centrifugation with established protocols

Protocol Recommendations:

• Protein loading: 20-40 μg per lane

• Gel percentage: 10-12% SDS-PAGE

• Transfer time: 60-90 minutes at 100V (wet transfer recommended)

• Blocking: 5% non-fat milk in TBST, 1 hour at room temperature

• Primary antibody: 1:500-1:1000 dilution, overnight at 4°C

• Secondary antibody: 1:5000-1:10000, 1 hour at room temperature

• Expected molecular weights: 50 kDa (primary band), 100 kDa (possible secondary band)

Researchers should be aware that sample-dependent optimization may be necessary . For troubleshooting purposes, RAW 264.7 cells serve as a positive control for SLC25A25 expression . When analyzing results, the presence of multiple bands should be carefully interpreted, as they may represent different isoforms or post-translational modifications rather than non-specific binding.

How should researchers optimize immunohistochemistry protocols for SLC25A25 detection?

For optimal immunohistochemical detection of SLC25A25 in tissue sections, researchers should consider the following methodological approach:

Tissue Preparation:

• Fix tissues in 10% neutral buffered formalin (10-24 hours)

• Process and embed in paraffin following standard protocols

• Section at 4-6 μm thickness

Antigen Retrieval (Critical Step):

• Primary recommendation: TE buffer pH 9.0

• Alternative method: Citrate buffer pH 6.0

• Heat-induced epitope retrieval: 95-98°C for 15-20 minutes

Staining Protocol:

• Block endogenous peroxidase: 3% H₂O₂ in methanol, 10 minutes

• Protein blocking: 5% normal serum, 1 hour

• Primary antibody incubation: 1:20-1:200 dilution, overnight at 4°C

• Detection system: Polymer-based detection system

• Chromogen: DAB (3,3'-diaminobenzidine)

• Counterstain: Hematoxylin

Controls:

• Positive control: Human liver tissue shows reliable staining

• Negative controls: Omit primary antibody

• Validation: Consider peptide competition assay to confirm specificity

Researchers should be aware that mitochondrial proteins like SLC25A25 typically show a punctate cytoplasmic staining pattern. Titration of the antibody concentration is essential, as the optimal dilution may vary depending on tissue type and fixation conditions .

What controls and validation methods are essential for SLC25A25 antibody experiments?

Rigorous validation of SLC25A25 antibodies is crucial for generating reliable and reproducible research data:

Essential Controls:

Validation Approaches:

• Multi-antibody validation: Use antibodies targeting different epitopes

• Recombinant expression: Overexpress tagged SLC25A25 and confirm co-localization

• Cross-technique validation: Confirm findings using orthogonal methods (e.g., immunoblotting and immunofluorescence)

• Demonstrate expected localization: Confirm mitochondrial localization using mitochondrial markers

For SLC25A25 specifically, researchers should be aware that the protein shows a characteristic mitochondrial distribution and has been detected at both 50 kDa and 100 kDa molecular weights in Western blot analyses . Any deviation from these expected patterns should prompt additional validation experiments.

How can researchers differentiate between SLC25A25 isoforms in experimental studies?

SLC25A25 exists in multiple isoforms due to alternative splicing, with documented variants including those that lack specific exons (e.g., exon 6) . Differentiating between these isoforms requires careful experimental design:

Isoform-Specific Detection Strategies:

• RT-PCR/qPCR Approach:

  • Design primers that span exon-exon junctions unique to specific isoforms

  • Use TaqMan probes designed from sequences in the C-terminal region to detect all four isoforms of human SLC25A25 (hSCaMC-2a to 2d)

  • Normalize expression to appropriate housekeeping genes (e.g., cyclophilin B for mouse studies, RPLPO for human studies)

• Protein Detection:

  • Use antibodies targeting regions absent in specific splice variants

  • Analyze molecular weight differences in Western blot (e.g., exon 6 deletion results in a smaller protein)

  • Consider 2D gel electrophoresis to separate isoforms with similar molecular weights

• Recombinant Expression:

  • Clone and express individual isoforms as reference standards

  • Generate isoform-specific knockdown models to confirm antibody specificity

The most common human SLC25A25 isoform corresponds to NCBI reference sequence NM146118, while an alternative isoform lacking exon 6 corresponds to NCBI reference sequence AK132201, similar to the human SCaMC-2b spliced variant . When designing experiments, researchers should be aware of which isoforms their antibodies will detect and interpret results accordingly.

How does SLC25A25 function relate to metabolic efficiency and obesity research?

SLC25A25's role in metabolic regulation presents significant implications for obesity and energy metabolism research:

Key Research Findings:

• Mice with inactivated Slc25a25 genes demonstrate enhanced resistance to diet-induced obesity

• SLC25A25 knockout mice exhibit reduced metabolic efficiency and impaired exercise performance on treadmills

• The absence of SLC25A25 reduces basal mitochondrial respiration and ATP content in mouse embryo fibroblasts

• SLC25A25 may be induced during cold adaptation in skeletal muscle, particularly in mice with defective UCP1/brown adipose tissue thermogenesis

Experimental Approaches for Metabolism Studies:

• Metabolic Phenotyping:

  • Indirect calorimetry to measure energy expenditure

  • Body composition analysis using DXA or NMR

  • Glucose and insulin tolerance tests

  • Exercise capacity testing (e.g., treadmill protocols)

• Tissue-Specific Analysis:

  • Mitochondrial respiratory function measurements

  • ATP production capacity assays

  • Calcium flux measurements across the endoplasmic reticulum

  • Quantification of SLC25A25 expression in different metabolic states

While SLC25A25 knockout mice show metabolic inefficiency, research indicates this is not primarily related to thermogenesis, as these mice can maintain body temperature upon acute cold exposure (4°C) . Instead, evidence suggests SLC25A25's metabolic effects are linked to muscle function, affecting the efficiency of ATP production required for skeletal muscle activity, with secondary effects on adiposity .

What molecular techniques are recommended for studying SLC25A25 in mitochondrial ATP transport?

Investigating SLC25A25's role in mitochondrial ATP transport requires specialized techniques:

Recommended Methodological Approaches:

• Mitochondrial Isolation and Functional Assays:

  • Percoll gradient centrifugation for high-purity mitochondrial isolation

  • Oxygen consumption measurement using respirometry (Seahorse XF or Oroboros)

  • Membrane potential assessment using potentiometric dyes (TMRM, JC-1)

  • ATP synthesis rate determination using luciferase-based assays

• Transport Kinetics Analysis:

  • Reconstitution of SLC25A25 in liposomes to study direct transport properties

  • Radiolabeled substrate uptake assays

  • Patch-clamp electrophysiology of mitoplasts

  • Calcium dependence studies using calcium chelators and ionophores

• Protein-Protein Interaction Studies:

  • Co-immunoprecipitation to identify interacting partners

  • Blue native PAGE to analyze native complex formation

  • Proximity labeling techniques (BioID, APEX)

  • FRET/BRET assays to study dynamic interactions

Since SLC25A25 is thought to control ATP homeostasis by functioning as a Ca²⁺-regulated shuttle of ATP-Mg²⁺ and Pi across the inner mitochondrial membrane , these approaches allow researchers to dissect the molecular mechanisms of this regulation and its physiological significance.

How do tissue-specific expression patterns impact SLC25A25 research design?

Understanding the tissue distribution of SLC25A25 is critical for experimental design:

Tissue Expression Patterns:

• Skeletal muscle: SLC25A25 is notably expressed and induced during adaptation to cold stress in mice with defective UCP1/brown adipose tissue thermogenesis

• Liver: Reliable detection in human liver tissue has been documented for IHC applications

• Other tissues: Expression patterns may vary across species and physiological conditions

Experimental Design Considerations:

• Tissue Selection:

  • For metabolic studies, skeletal muscle represents a primary tissue of interest

  • For proof-of-concept antibody validation, human liver tissue provides a reliable positive control

  • Include tissues with expected low expression as negative controls

• Conditional Knockout Approaches:

  • Consider tissue-specific Cre-loxP systems for targeted SLC25A25 deletion

  • Examples include creating floxed Slc25a25 alleles with loxP sites in introns flanking critical exons

• Expression Analysis:

  • Use tissue microarrays for broad expression profiling

  • Validate antibody performance in each tissue type

  • Consider single-cell approaches to identify cell-type specific expression

When studying SLC25A25, researchers should be aware that its expression may be regulated by physiological conditions such as cold exposure and metabolic stress . This contextual regulation necessitates careful experimental design that accounts for environmental conditions and physiological state.

What challenges exist in detecting SLC25A25 protein-protein interactions?

Investigating SLC25A25's interactions presents several technical challenges:

Common Challenges and Solutions:

• Membrane Protein Solubilization:

  • Challenge: Maintaining protein conformation during extraction

  • Solution: Use mild detergents (digitonin, DDM) or membrane-compatible crosslinkers

  • Validation: Compare results using different solubilization methods

• Transient Interactions:

  • Challenge: Ca²⁺-dependent interactions may be dynamic and difficult to capture

  • Solution: In situ proximity labeling (BioID, APEX2) or crosslinking

  • Analytical approach: Quantitative proteomics with appropriate controls

• Mitochondrial Localization:

  • Challenge: Distinguishing true interactions from co-localization

  • Solution: Super-resolution microscopy combined with FRET

  • Control: Include outer membrane proteins as negative controls

• Multiple Isoforms:

  • Challenge: Different isoforms may have distinct interaction partners

  • Solution: Isoform-specific tagging and purification

  • Analysis: Mass spectrometry with isoform-discriminating peptide detection

Since SLC25A25 functions as a Ca²⁺-regulated transporter , studying its protein-protein interactions requires techniques that can capture both stable structural interactions and transient regulatory interactions that may depend on calcium concentration or metabolic state.

How can researchers resolve common issues with SLC25A25 antibody staining patterns?

When encountering problems with SLC25A25 antibody staining, researchers should consider these troubleshooting approaches:

Western Blot Issues:

Immunohistochemistry Issues:

When interpreting staining patterns, remember that SLC25A25 is a mitochondrial protein, so the expected pattern should be cytoplasmic with a punctate distribution that may co-localize with mitochondrial markers. Any nuclear or membranous staining should be carefully validated.

What approaches help resolve contradictory findings when using different SLC25A25 antibodies?

When different antibodies targeting SLC25A25 yield conflicting results, systematic investigation is necessary:

Methodological Resolution Approaches:

• Epitope Mapping:

  • Identify the specific epitopes recognized by each antibody

  • Compare with sequence conservation across species and isoforms

  • Check for potential post-translational modifications that might affect epitope recognition

• Validation Using Genetic Models:

  • Test antibodies in SLC25A25 knockout or knockdown models

  • Use overexpression systems with tagged constructs

  • Compare antibody performance in samples with known expression levels

• Cross-Platform Validation:

  • Correlate protein detection with mRNA expression

  • Compare results across different techniques (WB, IHC, IF)

  • Use mass spectrometry for antibody-independent validation

• Antibody Characterization:

  • Perform peptide competition assays

  • Test batch-to-batch variability

  • Compare monoclonal and polyclonal antibodies targeting different regions

When analyzing contradictory results, consider that differences may reflect biological reality rather than technical issues—different antibodies may recognize distinct isoforms, conformations, or post-translationally modified forms of SLC25A25. Document and report these differences clearly in publications to advance the field's understanding.

How should researchers interpret variations in SLC25A25 expression across experimental models?

Variations in SLC25A25 expression between models require careful interpretation:

Factors Affecting Expression Variation:

• Physiological Regulators:

  • Metabolic state: SLC25A25 expression responds to energy demand

  • Temperature adaptation: Cold stress induces expression in skeletal muscle

  • Calcium signaling: May affect both expression and activity

• Species Differences:

  • Sequence variations may affect antibody recognition

  • Functional differences in energy metabolism between species

  • Differing roles in thermogenic adaptation

• Experimental Conditions:

  • Cell culture conditions can alter metabolic state

  • Tissue processing methods may affect protein preservation

  • Antibody sensitivity to fixation or extraction methods

Analytical Approaches:

• Use multiple antibodies targeting different epitopes

• Complement protein studies with mRNA quantification

• Perform parallel analyses across models under identical conditions

• Consider absolute quantification methods (e.g., AQUA peptides in mass spectrometry)

When interpreting expression data, researchers should consider that SLC25A25's role in metabolic efficiency may cause its expression to vary with physiological state, particularly in tissues like skeletal muscle that are central to its function . This contextual regulation should be accounted for in experimental design and data interpretation.

What statistical approaches are recommended for analyzing SLC25A25 expression data?

Appropriate statistical analysis is crucial for interpreting SLC25A25 expression data:

Recommended Statistical Methods:

• For Western Blot Densitometry:

  • Normalize to appropriate loading controls (mitochondrial markers preferred)

  • Use technical replicates (minimum n=3) and biological replicates

  • Apply log transformation for data with non-normal distribution

  • Analyze using t-tests (two groups) or ANOVA with post-hoc tests (multiple groups)

• For qPCR Analysis:

  • Normalize to validated reference genes (e.g., cyclophilin B for mouse, RPLPO for human)

  • Calculate relative expression using 2^(-ΔΔCt) method

  • Validate PCR efficiency for all primer pairs

  • Apply appropriate statistical tests based on experimental design

• For Immunohistochemistry Quantification:

  • Use validated digital image analysis algorithms

  • Analyze sufficient fields/samples for statistical power

  • Consider hierarchical statistical models for nested designs

  • Account for batch effects in multi-batch experiments

• For Multi-Omics Integration:

  • Apply correlation analysis between protein and mRNA data

  • Consider dimension reduction techniques for complex datasets

  • Use pathway analysis to interpret changes in biological context

  • Implement machine learning approaches for pattern recognition

When reporting results, researchers should clearly describe all statistical methods, include measures of variability (standard deviation or standard error), and provide exact p-values rather than threshold ranges. For phenotypic data related to SLC25A25 function (e.g., metabolic parameters), consider regression analyses to examine relationships between expression levels and functional outcomes.

What emerging technologies hold promise for advanced SLC25A25 research?

Several cutting-edge technologies are poised to advance our understanding of SLC25A25 biology:

• CRISPR-Based Approaches:

  • Base editing for introducing specific mutations

  • CRISPRi/CRISPRa for reversible modulation of expression

  • Prime editing for precise genetic modifications without double-strand breaks

• Advanced Imaging Techniques:

  • Super-resolution microscopy to visualize mitochondrial distribution

  • Live-cell calcium and ATP imaging to correlate with SLC25A25 activity

  • Correlative light and electron microscopy for ultrastructural analysis

• Single-Cell Technologies:

  • Single-cell proteomics to analyze expression heterogeneity

  • Spatial transcriptomics to map expression in tissue context

  • Multi-modal single-cell analysis combining genomics and proteomics

• Structural Biology Approaches:

  • Cryo-EM for structure determination in native-like environments

  • Hydrogen-deuterium exchange mass spectrometry for conformational dynamics

  • AlphaFold and related AI methods for structure prediction and function analysis

These technologies will help address key research questions regarding SLC25A25's structure-function relationships, regulatory mechanisms, and physiological roles in different tissues and metabolic states, potentially revealing new therapeutic targets for metabolic disorders.

How can researchers contribute to understanding the therapeutic potential of SLC25A25?

Given SLC25A25's involvement in metabolic regulation and obesity resistance , exploring its therapeutic potential requires systematic approaches:

• Translational Research Priorities:

  • Develop tissue-specific conditional knockout models

  • Investigate pharmacological modulators of SLC25A25 activity

  • Examine genetic variants in human cohorts with metabolic phenotypes

  • Explore the relationship between SLC25A25 and established metabolic pathways

• Methodological Considerations:

  • Design high-throughput screens for SLC25A25 modulators

  • Establish relevant cellular models for drug testing

  • Develop biomarkers for SLC25A25 activity in clinical samples

  • Create humanized mouse models for translational studies

• Collaborative Approaches:

  • Integrate clinical and basic research through biobanking

  • Combine expertise in mitochondrial biology and metabolism

  • Leverage systems biology to understand network effects

  • Partner with computational biologists for predictive modeling